Publication - 11/22/2013

FDA Final Guidance on Mobile Medical Applications

Life Sciences Now

On September 23, 2013, the FDA issued a guidance (“Final Guidance”) explaining how medical device regulations will be applied to medical mobile applications (MMAs). The Final Guidance provides mobile application manufacturers with recommendations on how to comply with the regulatory and statutory requirements governing medical devices. The Guidance indicates that the FDA intends to limit its enforcement authority to only those mobile applications that operate as medical devices and pose a significant risk to patients if they fail to function as intended.

The Final Guidance outlines three categories of mobile applications (mobile apps) generally: (1) mobile apps that are not medical devices as defined under the Federal Food, Drug, and Cosmetic Act and are therefore not subject to FDA regulation; (2) mobile apps that may meet the definition of a medical device but over which the FDA intends to exercise enforcement discretion because these applications pose a low risk to the public; and (3) mobile apps that meet the definition of a medical device and which the FDA will regulate due to the significant potential risk to patient safety.

To read the entire article, click here.

Bankruptcy Plans Go Up in Smoke: Marijuana Grower Denied Relief

The Legal Intelligencer
Joseph N. Argentina, Jr., Andrew C. Kassner

Andy Kassner and Joe Argentina discuss whether Colorado’s legal, licensed marijuana producers can avail themselves of federal bankruptcy law protection.

Debtor Sues Lenders for Alleged Violations of the Fair Credit Reporting Act

Creditors Digest
Stephen C. Baker, Christian Brito , Alan M. Kidd, Stephen A. Serfass, Nolan B. Tully

On September 18, 2015, Margaret M. Okamoto (“Plaintiff”) filed a complaint (the “Complaint”) in The United States District Court for the District of Nevada alleging violations of the Fair Credit Reporting Act, 15 U.S.C. § 1681 et seq. (the “FCRA”), against, inter alia, Bank of America, N.A. (“BOA”), Mutual of Omaha Bank (“MOB”), and Experian Information Solutions, Inc. (collectively, “Defendants”). See Okamoto v. Bank of America et al., No. 2:15-cv-01800-GMN-GWF (Sept. 18, 2015).

IRS Provides Guidance on Fund of Funds

Investment Management Alert
Brian DeVirgilio, Glenn E. Ferencz, Thomas Gray

On September 15, the Internal Revenue Service published final regulations revising examples related to the application of the controlled group rules to regulated investment companies (RIC) and how the controlled group rules affect the diversification tests that a RIC needs to satisfy.

Third Circuit Wraps Up Chocolate Price-Fixing Case

Antitrust Alert
Todd N. Hutchison, Brynne S. Madway, Paul H. Saint-Antoine

On September 15, 2015, the United States Court of Appeals for the Third Circuit affirmed the district court’s summary judgment decision in In re Chocolate Confectionary Antitrust Litigation, which we reported on last year.

Texas and California Appellate Courts Soundly Reject the Concept of Forced Servicing

Structured Settlement Alert
Stephen R. Harris, Michael J. Miller, Lisa D. Stern

Structured Settlement Protection Acts (SSPAs) have been enacted in 48 states to regulate structured settlement factoring transactions.